806 related articles for article (PubMed ID: 30710528)
41. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
42. Hormonally Induced Hepatocellular Carcinoma in Diabetic Wild Type and Carbohydrate Responsive Element Binding Protein Knockout Mice.
Nuernberger V; Mortoga S; Metzendorf C; Burkert C; Ehricke K; Knuth E; Zimmer J; Singer S; Nath N; Karim M; Yasser M; Calvisi DF; Dombrowski F; Ribback S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685767
[TBL] [Abstract][Full Text] [Related]
43. Hepatic C-X-C chemokine receptor type 6-expressing innate lymphocytes limit detrimental myeloid hyperactivation in acute liver injury.
Heymann F; Mossanen JC; Peiseler M; Niemietz PM; Araujo David B; Krenkel O; Liepelt A; Batista Carneiro M; Kohlhepp MS; Kubes P; Tacke F
Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972392
[TBL] [Abstract][Full Text] [Related]
44. IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice.
Weng HL; Feng DC; Radaeva S; Kong XN; Wang L; Liu Y; Li Q; Shen H; Gao YP; Müllenbach R; Munker S; Huang T; Chen JL; Zimmer V; Lammert F; Mertens PR; Cai WM; Dooley S; Gao B
J Hepatol; 2013 Oct; 59(4):738-45. PubMed ID: 23747755
[TBL] [Abstract][Full Text] [Related]
45. CXCR6-Deficiency Improves the Control of Pulmonary
Ashhurst AS; Flórido M; Lin LCW; Quan D; Armitage E; Stifter SA; Stambas J; Britton WJ
Front Immunol; 2019; 10():339. PubMed ID: 30899256
[TBL] [Abstract][Full Text] [Related]
46. CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice.
Ishikawa S; Ikejima K; Yamagata H; Aoyama T; Kon K; Arai K; Takeda K; Watanabe S
J Hepatol; 2011 Jun; 54(6):1195-204. PubMed ID: 21145835
[TBL] [Abstract][Full Text] [Related]
47. High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.
Qin WH; Yang ZS; Li M; Chen Y; Zhao XF; Qin YY; Song JQ; Wang BB; Yuan B; Cui XL; Shen F; He J; Bi YF; Ning G; Fu J; Wang HY
Gastroenterology; 2020 May; 158(6):1713-1727. PubMed ID: 31972238
[TBL] [Abstract][Full Text] [Related]
48. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
49. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
[TBL] [Abstract][Full Text] [Related]
50. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
Sun R; Tian Z; Kulkarni S; Gao B
J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
[TBL] [Abstract][Full Text] [Related]
51. CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.
Scaiewicz V; Nahmias A; Chung RT; Mueller T; Tirosh B; Shibolet O
PLoS One; 2013; 8(12):e81065. PubMed ID: 24339898
[TBL] [Abstract][Full Text] [Related]
52. Liver Injury After Invariant NKT Cell Activation by Free Alpha-galactosylceramide and Alpha-galactosylceramide-loaded Dendritic Cells.
Hasegawa H; Yamashita K; Otsubo D; Kakeji Y
Anticancer Res; 2016 Jul; 36(7):3667-72. PubMed ID: 27354638
[TBL] [Abstract][Full Text] [Related]
53. NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.
Sadegh L; Chen PW; Brown JR; Han Z; Niederkorn JY
Int J Cancer; 2015 Sep; 137(5):1085-94. PubMed ID: 25683463
[TBL] [Abstract][Full Text] [Related]
54. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
55. Exercise retards hepatocarcinogenesis in obese mice independently of weight control.
Arfianti A; Pok S; Barn V; Haigh WG; Yeh MM; Ioannou GN; Teoh NC; Farrell GC
J Hepatol; 2020 Jul; 73(1):140-148. PubMed ID: 32302728
[TBL] [Abstract][Full Text] [Related]
56. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
Lai KKY; Kweon SM; Chi F; Hwang E; Kabe Y; Higashiyama R; Qin L; Yan R; Wu RP; Lai K; Fujii N; French S; Xu J; Wang JY; Murali R; Mishra L; Lee JS; Ntambi JM; Tsukamoto H
Gastroenterology; 2017 May; 152(6):1477-1491. PubMed ID: 28143772
[TBL] [Abstract][Full Text] [Related]
57. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
[TBL] [Abstract][Full Text] [Related]
58. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells.
Kenna T; Golden-Mason L; Porcelli SA; Koezuka Y; Hegarty JE; O'Farrelly C; Doherty DG
J Immunol; 2003 Aug; 171(4):1775-9. PubMed ID: 12902477
[TBL] [Abstract][Full Text] [Related]
59. A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine.
Fujii H; Seki S; Kobayashi S; Kitada T; Kawakita N; Adachi K; Tsutsui H; Nakanishi K; Fujiwara H; Ikarashi Y; Taniguchi M; Kronenberg M; Ikemoto M; Nakajima Y; Arakawa T; Kaneda K
Virchows Arch; 2005 Jun; 446(6):663-73. PubMed ID: 15906084
[TBL] [Abstract][Full Text] [Related]
60. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]